Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas

Endocrine-Related Cancer

Volumn 19, Issue 1, 2012, Pages 95-99

  Kamp, Kimberly ^a   Damhuis, Ronald A M ^b   Feelders, Richard A ^a   De Herder, Wouter W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Rotterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL TRACT AND PANCREAS NEUROENDOCRINE TUMOR; GASTROINTESTINAL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MELANOMA; METHODOLOGY; NEUROENDOCRINE TUMOR; PANCREAS NEUROENDOCRINE TUMOR; PATHOPHYSIOLOGY; POISSON DISTRIBUTION; PREVALENCE; PROSTATE CANCER; RISK FACTOR; SECOND CANCER; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROGNOSIS; YOUNG ADULT;

EID: 84860909169     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0315     Document Type: Article

References (19)

1. Breslow NE & Day NE 1987 The analysis of cohort studies. Statistical Methods in Cancer Research, vol 2. Lyon, France: IARC Scientific Publications.
2. Bzhalava D, Bray F, Storm H & Dillner J 2011 Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia. British Journal of Cancer 104 178-180. (doi:10.1038/sj.bjc.6605989)
3. Cote ML, Wenzlaff AS, Philip PA & Schwartz AG 2006 Secondary cancers after a lung carcinoid primary: a population-based analysis. Lung Cancer 52 273-279. (doi:10.1016/j.lungcan.2006.02.004)
4. Gerstle JT, Kauffman GL Jr & Koltun WA 1995 The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. Journal of the American College of Surgeons 180 427-432.
5. Habal N, Sims C & Bilchik AJ 2000 Gastrointestinal carcinoid tumors and second primary malignancies. Journal of Surgical Oncology 75 310-316. (doi:10.1002/1096-9098(200012)75:4〈306::AID-JSO14〉3.0.CO;2-3)
6. Halfdanarson TR, Rabe KG, Rubin J & Petersen GM 2008a Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Annals of Oncology 19 1727-1733. (doi:10.1093/annonc/mdn351)
7. Halfdanarson TR, Rubin J, Farnell MB, Grant CS & Petersen GM 2008b Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocrine-Related Cancer 15 409-427. (doi:10.1677/ERC-07-0221)
8. Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J & Melbye M 2010 Merkel cell carcinoma: incidence, mortality, and risk of other cancers. Journal of the National Cancer Institute 102 793-801. (doi:10.1093/jnci/djq120)
9. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M & Modlin IM 2011 The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinology and Metabolism Clinics of North America 40 1-18. (doi:10.1016/j.ecl.2010.12.005)
10. Li AF, Hsu CY, Li A, Tai LC, Liang WY, Li WY, Tsay SH & Chen JY 2008 A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Cancer 112 274-283. (doi:10.1002/cncr.23159)
11. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP et al. 2008 Gastroenteropancreatic neuroendocrine tumours. Lancet Oncology 9 61-72. (doi:10.1016/S1470-2045(07) 70410-2)
12. Niederle MB, Hackl M, Kaserer K & Niederle B 2010 Gastro-entero-pancreatic neuroendocrine tumours - the current incidence and staging based on the WHO and ENETS classification. Endocrine-Related Cancer 17 909-918. (doi:10.1677/ERC-10-0152)
13. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M & Komminoth P 2006 TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 449 395-401. (doi:10.1007/s00428-006-0250-1)
14. Rindi G, Kloppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A et al. 2007 TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 451 757-762. (doi:10.1007/s00428-007-0452-1)
15. Schneider C, Wittekind C & Kockerling F 1995 Aussergewöhnliche Häufung von Carcinoidtumoren und Zweitmalignomen. Chirurg 66 607-611.
16. Tulinius H, Storm HH, Pukkala E, Andersen A & Ericsson J 1992 Cancer in the Nordic countries, 1981-86. A joint publication of the five Nordic Cancer Registries. Acta Pathologica, Microbiologica, et Immunologica Scandinavica Supplement 31 1-194.
17. Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M & Evans DB 2007 Population-based study of islet cell carcinoma. Annals of Surgical Oncology 14 3492-3500. (doi:10.1245/s10434-007-9566-6)
18. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A et al. 2008 One hundred years after 'carcinoid': epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States. Journal of Clinical Oncology 26 3063-3072. (doi:10.1200/JCO.2007.15.4377)
19. Zar N, Garmo H, Holmberg L & Hellman P 2008 Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine. European Journal of Cancer 44 718-725. (doi:10.1016/j.ejca.2007.12.003)